| Manager | Title | Age | Since |
|---|---|---|---|
Fulvio Citaredo
CEO | Chief Executive Officer | 64 | 2011-12-31 |
Francesco Pepe
DFI | Director of Finance/CFO | 47 | 2017-06-11 |
Fabio Velotti
SAM | Sales & Marketing | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Raffaele Petrone
CHM | Chairman | 61 | 2014-10-08 |
Mauro Fierro
BRD | Director/Board Member | 66 | 2012-05-21 |
Fulvio Citaredo
BRD | Director/Board Member | 64 | 2011-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.58% | - | - | 105M | ||
| -0.11% | -3.16% | +48.82% | +91.49% | 1,001B | ||
| -0.27% | -4.34% | +51.52% | +65.89% | 642B | ||
| +1.63% | -2.00% | +20.49% | +71.12% | 451B | ||
| +0.20% | -2.86% | +29.21% | +36.59% | 340B | ||
| +0.61% | -12.75% | +11.08% | +28.03% | 263B | ||
| +0.31% | -1.65% | -1.24% | +12.44% | 247B | ||
| -2.25% | -13.88% | +37.33% | +47.43% | 207B | ||
| -2.66% | -6.89% | -19.54% | -59.31% | 197B | ||
| -0.58% | -4.24% | +25.65% | +90.54% | 180B | ||
| Average | -0.19% | -5.53% | +22.59% | +42.69% | 391.82B | |
| Weighted average by Cap. | +0.07% | -4.65% | +31.81% | +57.62% |
Employees
105
Sector
Pharmaceuticals
















